50
Participants
Start Date
May 3, 2018
Primary Completion Date
April 20, 2020
Study Completion Date
April 20, 2020
Eculizumab (JSC GENERIUM, Russia)
Eculizumab
"Federal State Budgetary Institution National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation", Moscow
State Budgetary Institution of Healthcare of the City of Moscow City Clinical Hospital named after S.P. Botkin of the Moscow Department of Health, Moscow
"State budgetary institution of health care of the Moscow region Moscow Regional Research Clinical Institute named after M.F. Vladimirsky", Moscow
"Federal State Budgetary Educational Institution of Higher Education First St. Petersburg State Medical University named after Academician I.P. Pavlov", Saint Petersburg
"State budgetary institution of the Rostov region Rostov Regional Clinical Hospital", Rostov-on-Don
"Federal State Budgetary Educational Institution of Higher Education Samara State Medical University of the Ministry of Health of the Russian Federation", Samara
"State budgetary healthcare institution Chelyabinsk Regional Clinical Hospital", Chelyabinsk
"Federal State Budgetary Institution of Science Kirov Research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency", Kirov
"State Budgetary Healthcare Institution of the Sverdlovsk Region Sverdlovsk Regional Clinical Hospital No. 1", Yekaterinburg
AO GENERIUM
INDUSTRY